These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Anti-tissue transglutaminase antibodies from coeliac patients inhibit transglutaminase activity both in vitro and in situ. Esposito C; Paparo F; Caputo I; Rossi M; Maglio M; Sblattero D; Not T; Porta R; Auricchio S; Marzari R; Troncone R Gut; 2002 Aug; 51(2):177-81. PubMed ID: 12117875 [TBL] [Abstract][Full Text] [Related]
4. Biochemical and immuno-pathological aspects of tissue transglutaminase in coeliac disease. Roth EB; Sjöberg K; Stenberg P Autoimmunity; 2003 Jun; 36(4):221-6. PubMed ID: 14563015 [TBL] [Abstract][Full Text] [Related]
5. Transglutaminase and coeliac disease: endomysial reactivity and small bowel expression. Brusco G; Muzi P; Ciccocioppo R; Biagi F; Cifone MG; Corazza GR Clin Exp Immunol; 1999 Dec; 118(3):371-5. PubMed ID: 10594554 [TBL] [Abstract][Full Text] [Related]
6. Gliadin and tissue transglutaminase complexes in normal and coeliac duodenal mucosa. Ciccocioppo R; Di Sabatino A; Ara C; Biagi F; Perilli M; Amicosante G; Cifone MG; Corazza GR Clin Exp Immunol; 2003 Dec; 134(3):516-24. PubMed ID: 14632760 [TBL] [Abstract][Full Text] [Related]
7. Antibody responses to deamidated gliadin peptide show high specificity and parallel antibodies to tissue transglutaminase in developing coeliac disease. Ankelo M; Kleimola V; Simell S; Simell O; Knip M; Jokisalo E; Tarkia M; Westerlund A; He Q; Viander M; Ilonen J; Hinkkanen AE Clin Exp Immunol; 2007 Nov; 150(2):285-93. PubMed ID: 17803713 [TBL] [Abstract][Full Text] [Related]
8. Evidence for existence of coeliac disease autoantigens apart from tissue transglutaminase. Uhlig HH; Lichtenfeld J; Osman AA; Richter T; Mothes T Eur J Gastroenterol Hepatol; 2000 Sep; 12(9):1017-20. PubMed ID: 11007139 [TBL] [Abstract][Full Text] [Related]
9. Elevation of IgG antibodies against tissue transglutaminase as a diagnostic tool for coeliac disease in selective IgA deficiency. Korponay-Szabó IR; Dahlbom I; Laurila K; Koskinen S; Woolley N; Partanen J; Kovács JB; Mäki M; Hansson T Gut; 2003 Nov; 52(11):1567-71. PubMed ID: 14570724 [TBL] [Abstract][Full Text] [Related]
10. [Relevance of anti-tissue transglutaminase antibodies in coeliac disease diagnosis]. Lepers S; Soula F; Fily S; Fontaine E; Vuye S; Colombel JF; Guimber D; Prin L; Dubucquoi S Ann Biol Clin (Paris); 2003; 61(3):337-43. PubMed ID: 12805013 [TBL] [Abstract][Full Text] [Related]
11. Prospective screening for coeliac disease in patients with Graves' hyperthyroidism using anti-gliadin and tissue transglutaminase antibodies. Ch'ng CL; Biswas M; Benton A; Jones MK; Kingham JG Clin Endocrinol (Oxf); 2005 Mar; 62(3):303-6. PubMed ID: 15730411 [TBL] [Abstract][Full Text] [Related]
12. Correlation analysis of celiac sprue tissue transglutaminase and deamidated gliadin IgG/IgA. Marietta EV; Rashtak S; Murray JA World J Gastroenterol; 2009 Feb; 15(7):845-8. PubMed ID: 19230045 [TBL] [Abstract][Full Text] [Related]
13. Diagnostic utility of deamidated gliadin peptide antibody in celiac disease compared to anti-tissue transglutaminase and IgA- endomysium antibodies. Sayed SK; Imam HM; Mahran AM; Refaiy AM Egypt J Immunol; 2012; 19(2):41-52. PubMed ID: 23885406 [TBL] [Abstract][Full Text] [Related]
14. [Predictive value of serological tests in the diagnosis of celiac disease]. Carroccio A; Di Prima L; Falci C; Le Moli C; Soresi M; Montalto G; Notarbartolo A Ann Ital Med Int; 2002; 17(2):102-7. PubMed ID: 12150043 [TBL] [Abstract][Full Text] [Related]
15. Tissue transglutaminase antibodies in celiac disease, comparison of an enzyme linked immunosorbent assay and a dot blot assay. Mankaï A; Sakly W; Landolsi H; Gueddah L; Sriha B; Ayadi A; Sfar MT; Skandrani K; Harbi A; Essoussi AS; Korbi S; Fabien N; Jeddi M; Ghedira I Pathol Biol (Paris); 2005 May; 53(4):204-9. PubMed ID: 15850953 [TBL] [Abstract][Full Text] [Related]
16. Affinity maturation of immunoglobulin A anti-tissue transglutaminase autoantibodies during development of coeliac disease. Westerlund A; Ankelo M; Simell S; Ilonen J; Knip M; Simell O; Hinkkanen AE Clin Exp Immunol; 2007 May; 148(2):230-40. PubMed ID: 17286799 [TBL] [Abstract][Full Text] [Related]
17. IgA antibodies against deamidated gliadin peptides in patients with chronic liver diseases. Gatselis NK; Zachou K; Norman GL; Tzellas G; Speletas M; Gabeta S; Germenis A; Koukoulis GK; Dalekos GN Clin Chim Acta; 2012 Oct; 413(19-20):1683-8. PubMed ID: 22643316 [TBL] [Abstract][Full Text] [Related]
18. Mutagenesis of the catalytic triad of tissue transglutaminase abrogates coeliac disease serum IgA autoantibody binding. Byrne G; Ryan F; Jackson J; Feighery C; Kelly J Gut; 2007 Mar; 56(3):336-41. PubMed ID: 16935926 [TBL] [Abstract][Full Text] [Related]
19. Neo-epitope tissue transglutaminase autoantibodies as a biomarker of the gluten sensitive skin disease--dermatitis herpetiformis. Lytton SD; Antiga E; Pfeiffer S; Matthias T; Szaflarska-Poplawska A; Ulaganathan VK; Placek W; Fabbri P; Hall R; Caproni M Clin Chim Acta; 2013 Jan; 415():346-9. PubMed ID: 23142793 [TBL] [Abstract][Full Text] [Related]
20. Binding of autoantibodies to the core region of tissue transglutaminase is a feature of paediatric coeliac disease. Comerford R; Byrne G; Feighery C; Kelly J J Pediatr Gastroenterol Nutr; 2012 Oct; 55(4):445-50. PubMed ID: 22383027 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]